PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus Type 2, and Diabetes Mellitus, Type 2, among others.
Pfizer Investigational Site, Orlando, Florida, United States
Pfizer Investigational Site, DeLand, Florida, United States
Pfizer Investigational Site, New Haven, Connecticut, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Pfizer Investigational Site, Chula Vista, California, United States
Profil Institute for Clinical Research, Inc., Chula Vista, California, United States
Pfizer Investigational Site, South Miami, Florida, United States
Pfizer Investigational Site, South Miami, Florida, United States
Pfizer Investigational Site, South Miami, Florida, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.